These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33070435)

  • 21. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
    Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
    Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-quantum-dot tracking reveals altered membrane dynamics of an attention-deficit/hyperactivity-disorder-derived dopamine transporter coding variant.
    Kovtun O; Sakrikar D; Tomlinson ID; Chang JC; Arzeta-Ferrer X; Blakely RD; Rosenthal SJ
    ACS Chem Neurosci; 2015 Apr; 6(4):526-34. PubMed ID: 25747272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant.
    Thal LB; Tomlinson ID; Quinlan MA; Kovtun O; Blakely RD; Rosenthal SJ
    ACS Chem Neurosci; 2019 Jan; 10(1):460-471. PubMed ID: 30153408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
    Hall FS; Sora I; Hen R; Uhl GR
    PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.
    Hall FS; Li XF; Randall-Thompson J; Sora I; Murphy DL; Lesch KP; Caron M; Uhl GR
    Neuroscience; 2009 Sep; 162(4):870-80. PubMed ID: 19482066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral Phenotype in Heterozygous DAT Rats: Transgenerational Transmission of Maternal Impact and the Role of Genetic Asset.
    Manoni G; Puzzo C; Gigantesco A; Adriani W
    Brain Sci; 2022 Mar; 12(4):. PubMed ID: 35448000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of Cdk5 activity is involved on Dopamine Transporter expression and function: Evidences from an animal model of Attention-Deficit Hyperactivity Disorder.
    Fernández G; Krapacher F; Ferreras S; Quassollo G; Mari MM; Pisano MV; Montemerlo A; Rubianes MD; Bregonzio C; Arias C; Paglini MG
    Exp Neurol; 2021 Dec; 346():113866. PubMed ID: 34537209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of dopamine transporter knockout mice as an animal model of AD/HD].
    Kasahara Y; Kubo Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):185-9. PubMed ID: 25069256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prior fear conditioning does not impede enhanced active avoidance in serotonin transporter knockout rats.
    Schipper P; Henckens MJAG; Borghans B; Hiemstra M; Kozicz T; Homberg JR
    Behav Brain Res; 2017 May; 326():77-86. PubMed ID: 28286283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear.
    Falzone TL; Gelman DM; Young JI; Grandy DK; Low MJ; Rubinstein M
    Eur J Neurosci; 2002 Jan; 15(1):158-64. PubMed ID: 11860516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice.
    Chen R; Furman CA; Zhang M; Kim MN; Gereau RW; Leitges M; Gnegy ME
    J Pharmacol Exp Ther; 2009 Mar; 328(3):912-20. PubMed ID: 19098163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
    Uchiumi O; Kasahara Y; Fukui A; Hall FS; Uhl GR; Sora I
    Neuropharmacology; 2013 Jan; 64():348-56. PubMed ID: 22809709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
    Del'Guidice T; Lemasson M; Etiévant A; Manta S; Magno LA; Escoffier G; Roman FS; Beaulieu JM
    Psychopharmacology (Berl); 2014 Jan; 231(1):109-22. PubMed ID: 23912772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
    Sakrikar D; Mazei-Robison MS; Mergy MA; Richtand NW; Han Q; Hamilton PJ; Bowton E; Galli A; Veenstra-Vanderweele J; Gill M; Blakely RD
    J Neurosci; 2012 Apr; 32(16):5385-97. PubMed ID: 22514303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.
    Giangrasso DM; Furlong TM; Keefe KA
    Neurobiol Dis; 2020 Feb; 134():104673. PubMed ID: 31734455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADHD and the dopamine transporter: are there reasons to pay attention?
    Mazei-Robinson MS; Blakely RD
    Handb Exp Pharmacol; 2006; (175):373-415. PubMed ID: 16722244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice.
    Medvedev IO; Gainetdinov RR; Sotnikova TD; Bohn LM; Caron MG; Dykstra LA
    Psychopharmacology (Berl); 2005 Jul; 180(3):408-13. PubMed ID: 15719221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards trans-diagnostic mechanisms in psychiatry: neurobehavioral profile of rats with a loss-of-function point mutation in the dopamine transporter gene.
    Vengeliene V; Bespalov A; Roßmanith M; Horschitz S; Berger S; Relo AL; Noori HR; Schneider P; Enkel T; Bartsch D; Schneider M; Behl B; Hansson AC; Schloss P; Spanagel R
    Dis Model Mech; 2017 Apr; 10(4):451-461. PubMed ID: 28167616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits.
    Reinwald JR; Gass N; Mallien AS; Sartorius A; Becker R; Sack M; Falfan-Melgoza C; Clemm von Hohenberg C; Leo D; Pfeiffer N; Middelman A; Meyer-Lindenberg A; Homberg JR; Weber-Fahr W; Gass P
    Mol Psychiatry; 2022 Apr; 27(4):2329-2339. PubMed ID: 35246636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
    Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
    J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.